Lupron Depot Alternatives Compared
| Lupron Depot (leuprolide) | Norethindrone | Leuprolide |
|
|---|
| Lupron Depot (leuprolide) | Norethindrone | Leuprolide |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Lupron Depot is a hormone deprivation treatment that may be used for the palliative care of advanced prostate cancer. The main side effects are hot flashes and general pain and it may cause... View more |
Prescription only
Prescribed for Endometriosis, Abnormal Uterine Bleeding, Gender Affirming Hormone Therapy , Amenorrhea, Birth Control. Norethindrone may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Prostate Cancer, Endometriosis, Uterine Fibroids, Breast Cancer - Adjuvant, Precocious Puberty, Female Infertility, Hirsutism, Uterine Leiomyomata. Leuprolide may also be used for... View more |
Related suggestions |
|||||||||||||||||||||||
| More about Lupron Depot (leuprolide) | More about Norethindrone | More about Leuprolide | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Lupron Depot has an average rating of 5.8 out of 10 from a total of 220 ratings on Drugs.com. 44% of reviewers reported a positive effect, while 33% reported a negative effect. |
Norethindrone has an average rating of 4.9 out of 10 from a total of 1566 ratings on Drugs.com. 33% of reviewers reported a positive effect, while 45% reported a negative effect. |
Leuprolide has an average rating of 5.7 out of 10 from a total of 390 ratings on Drugs.com. 43% of reviewers reported a positive effect, while 34% reported a negative effect. |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Side Effects | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
Lower cost generic |
Lower cost generic |
|||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Lupron Depot prices |
View all Norethindrone prices |
View all Leuprolide prices |
||||||||||||||||||||||||
| Dosage Forms Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Other leuprolide brands include: Camcevi, Eligard, Fensolvi, Lupron, Lupron Depot-PED | Affodel, Camila, Deblitane, Emzahh, Errin, Gallifrey, Heather, Incassia, Jencycla, Lyleq, Lyza, Nor-QD, Norlyda, Norlyroc, Sharobel, Tulana View more | Camcevi, Eligard, Fensolvi, Lupron, Lupron Depot, Lupron Depot-PED | ||||||||||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
|
4.25 hours |
10 hours |
4.25 hours |
||||||||||||||||||||||||
| CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 280 drugs are known to interact with Lupron Depot:
|
A total of 261 drugs are known to interact with Norethindrone:
|
A total of 280 drugs are known to interact with Leuprolide:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
January 26, 1989 |
April 21, 1982 |
January 26, 1989 |
||||||||||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.